Intravesical sequential gemcitabine/docetaxel for non-muscle invasive bladder cancer: tips and tricks for better efficacy and tolerability

被引：0
|
作者：
Abou Chakra, Mohamad [1 ]
Moussa, Mohamad [2 ]
O'Donnell, Michael A. [1 ]
机构：
[1] Univ IA, Dept Urol, Iowa City, IA 52242 USA
[2] Lebanese Univ, Al Zahraa Hosp, Dept Urol, Beirut, Lebanon
来源：
JOURNAL OF CHEMOTHERAPY | 2024年 / 36卷 / 08期
关键词：
RESCUE THERAPY; DOCETAXEL;
D O I：
10.1080/1120009X.2024.2325765
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：694 / 697
页数：4
相关论文
共 50 条
  • [1] Sequential Intravesical Gemcitabine and Docetaxel for the Salvage Treatment of Non-Muscle Invasive Bladder Cancer
    Steinberg, Ryan L.
    Thomas, Lewis J.
    O'Donnell, Michael A.
    Nepple, Kenneth G.
    BLADDER CANCER, 2015, 1 (01) : 65 - 72
  • [2] SEQUENTIAL INTRAVESICAL GEMCITABINE AND DOCETAXEL FOR THE SALVAGE TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER
    Steinberg, Ryan
    Thomas, Lewis
    O'Donnell, Michael
    Nepple, Kenneth
    JOURNAL OF UROLOGY, 2015, 193 (04): : E301 - E301
  • [3] Experience with Sequential Intravesical Gemcitabine and Docetaxel as Salvage Therapy for Non-Muscle Invasive Bladder Cancer
    Velaer, Kyla N.
    Steinberg, Ryan L.
    Thomas, Lewis J.
    O'Donnell, Michael A.
    Nepple, Kenneth G.
    CURRENT UROLOGY REPORTS, 2016, 17 (05)
  • [4] Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder Cancer
    Milbar, Niv
    Kates, Max
    Chappidi, Meera R.
    Pederzoli, Filippo
    Yoshida, Takahiro
    Sankin, Alexander
    Pierorazio, Phillip M.
    Schoenberg, Mark P.
    Bivalacqua, Trinity J.
    BLADDER CANCER, 2017, 3 (04) : 293 - 303
  • [5] Experience with Sequential Intravesical Gemcitabine and Docetaxel as Salvage Therapy for Non-Muscle Invasive Bladder Cancer
    Kyla N. Velaer
    Ryan L. Steinberg
    Lewis J. Thomas
    Michael A. O’Donnell
    Kenneth G. Nepple
    Current Urology Reports, 2016, 17
  • [6] Early experience with sequential intravesical gemcitabine and docetaxel for micropapillary variant non-muscle invasive bladder cancer
    Chakra, Mohamad Abou
    Mcelree, Ian M.
    Packiam, Vignesh T.
    Mott, Sarah L.
    O'Donnell, Michael A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (09) : 289e13 - 289e21
  • [7] Intravesical gemcitabine for non-muscle invasive bladder cancer
    Han, Mi Ah
    Maisch, Philipp
    Jung, Jae Hung
    Hwang, Jun Eul
    Narayan, Vikram
    Cleves, Anne
    Hwang, Eu Chang
    Dahm, Philipp
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (06):
  • [8] Intravesical gemcitabine for non-muscle invasive bladder cancer
    Jones, Gabriel
    Cleves, Anne
    Wilt, Timothy J.
    Mason, Malcolm
    Kynaston, Howard G.
    Shelley, Mike
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (01):
  • [9] Intravesical Gemcitabine for non-muscle invasive Bladder Cancer
    Krabbe, L. -M.
    Schmidt, S.
    UROLOGE, 2015, 54 (03): : 402 - 405
  • [10] Sequential intravesical gemcitabine and docetaxel in the treatment of BCG-naive patients with non-muscle invasive bladder cancer.
    Thomas, Lewis
    Steinberg, Ryan
    Nepple, Kenneth Gerard
    O'Donnell, Michael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
12345